ClinicalTrials.gg
Not yet recruitingNCT07216924Updated Oct 29, 2026

Remapping Text in Sentence and Word Tasks to Aid Reading With Central Vision Loss

An interventional study of Personalised Remapping Training and RSVP personalized remappi in Macular Degeneration and Central Visual Impairment, sponsored by University of Minnesota. Not yet recruiting at 1 site in United States. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2026-10-29.

Sponsored by University of Minnesota · Not applicable, Interventional, and Basic science

Updated Oct 29, 2026Enrollment updatedGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
216
Allocation
Randomized
Ages
16 Years and older
Sex
All
01

Study summary

Reading performance in patients with Central Vision Loss will be measured with and without missing text being remapped to different parts of the visual field in a variety of different reading tasks.

Read the detailed description

Following initial characterization of their visual field loss, the participant's performance in various reading tasks will be measured with and without remapping. Tasks will include reading simple sentences, reading popular fiction, reading text with one word presented at a time (rapid serial visual presentation, RSVP), and reading text in simulated real-world environments in virtual reality (e.g. subway station, school, city street). Different remapping strategies, e.g. mainly shifting the text horizontally, or vertically, will be tested.

Participants interested in the study will be brought in for an initial visit where they will first be consented. Participants will then undergo a standard exam at the UMN eye clinic, if they have not had one within the last month. Participants will then have their scotomas mapped using a microperimeter housed in the Ophthalmology department to give size and shape information. Participants will perform visual tasks that are used as the basis of their personalized remapping, letter perimetry. Participants will first view and report three randomly selected horizontally arranged letters placed at different locations in the visual field. This letter perimetry task will take about 40 min and will cover a large part of the visual field. Participants will then read single words whose letters have been displaced from horizontal in various ways that comprise candidate remappings generated on the basis of the letter perimetry results. This personalization test will take about 40 minutes, and will find a good remapping strategy for the individual. Subjects will then be introduced to the reading tasks that comprise the remainder of the study The study then branches into three arms. In one arm, participants will be given repeated practice reading sentences with remappings. In XX additional sessions, participants will perform a single sentence reading tasks for remapped and non-remapped text: One sentence at a time will be displayed on the screen, and the task is simply to read aloud what was presented. Following blocks of this task with and without remapping, participants will be given extended practice reading with remapping. Participants read multiple sentences from a longer text (popular fiction) in multiple 10 minute blocks. Each sentence will be presented individually, and participants will continuously read one sentence after another taken from the fiction text.

In a second arm, participants will read sentences with one word at a time presented in rapid succession. This form of reading is called rapid serial visual presentation or RSVP. In an initial block of sentences, different word rates will be tested to determine the fastest rate where participants are accurate, with and without remapping. Then individual sentences and longer passages will be read as in the other arm, but with this different presentation method. Different remappings and no remapping will again be tested.

In a third arm, participants will read single words presented in naturalistic scenes viewed in a virtual reality environment and presented on a head mounted display. Words will be read with and without remapping. Several different environments will be tested (e.g. subway station, school, city street). The words will be natural text that could be found in these environments, e.g. subway station names, messages on a chalkboard, storefront shop names, etc.

In all sessions in all arms, the eye tracker will be calibrated to participants' individual head and eye position. This will involve fixating at different points on the device screen (HMD or desk-mounted) as the eye is imaged by the eye trackers. Throughout all testing, patients will be asked if they feel any discomfort, and will be able to take a break or quit testing at any point. Reading responses will be verbal and will scored for accuracy by a research assistant.

Including the initial visit, testing for any given patient is anticipated to last no more than 16 sessions over sixteen weeks. Enrolling participants, testing, and data analysis for all participants is anticipated to take five years from the date of enrollment of the first participant.

02

Conditions studied

  • Macular Degeneration
  • Central Visual Impairment

Keywords

  • Reading
  • Central Field Loss
03

In context

Macular Degeneration

1,459 studies on the registry are indexed under Macular Degeneration; 238 are open to participants now.

This study's planned enrollment of 216 is above the median of 56 across 985 interventional studies indexed under Macular Degeneration.

Browse Macular Degeneration studies →

Lead sponsor

University of Minnesota is the lead sponsor of 1,216 studies on the registry; 197 are open to participants now.

Of its 136 completed or terminated interventional studies of FDA-regulated products, 95 (70%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Dense bilateral scotomas of at least 2 deg diameter in each eye covering the fovea
  • Bivariate contour ellipse area (BCEA) of less than 10\^2 is obtained in a simple fixation task

Exclusion criteria

Exclusion Criteria:

  • Neovascular AMD
  • Any history of visual disorders other than that causing the central vision loss.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
216 participants (estimated)

Study arms

  • Experimental
    Perceptual Learning

    Participants will practice reading with remapping over many sessions on different days.

    Behavioral: Personalised Remapping Training

  • Experimental
    Rapid Serial Visual Presentation

    Participants will read words presented one at a time in rapid succession near fixation.

    Behavioral: RSVP personalized remappi

  • Experimental
    Reading in The Wild

    Participants will view scenes in virtual reality showing natural settings and read a single word at a time within those scenes- e.g. a name on a street sign or shop in a city scene.

    Behavioral: Reading text in the wild with remapping

Interventions

  • BehavioralPersonalised Remapping Training

    Participants will receive training across multiple days with text being shifted in real time as it is being read from locations covered by scotoma to locations determined by personalization procedure .

  • BehavioralRSVP personalized remappi

    Participants will read one word at a time presented in rapid succession at fixation with text being shifted from scotoma locations to locations determined by personalization procedure.

  • BehavioralReading text in the wild with remapping

    Participants will read short texts presented in natural scenes in virtual reality with text being shifted from scotoma locations to locations determined by personalization procedure.

06

What researchers measure

Primary outcomes

  1. Sentence reading speed

    Time it took to read sentence in words per minute

    Time frame: Measured on day 35, end of the Personalised Remapping Training in the 33 participants in the Perceptual Learning arm.

  2. Sentence reading accuracy

    Percentage of correctly read words in sentence

    Time frame: Measured on day 35, end of the Personalised Remapping Training in the 33 participants in the Perceptual Learning arm.

  3. Word reading speed: RSVP

    Time taken to read each word

    Time frame: Measured on day 21, end of the RSVP Remapping intervention in the 33 participants in the Rapid Serial Visual Presentation arm.

  4. Word recognition accuracy: RSVP

    Percentage of words correctly read

    Time frame: Measured on day 21, end of the RSVP Remapping intervention in the 33 participants in the Rapid Serial Visual Presentation arm.

  5. Word reading speed: Reading in The Wild

    Time taken to read each word

    Time frame: Measured on day 21, end of the Reading Text in The Wild with Remapping intervention in the 33 participants in the Reading in The Wild arm.

  6. Word recognition accuracy: Reading in the wild

    Percentage of words correctly read

    Time frame: Measured on day 21, end of the Reading Text in The Wild with Remapping intervention in the 33 participants in the Reading in The Wild arm.

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — Psychophysical (behavioral) data on reading will be gathered from 32 participants each in 3 experiments. Scotoma shape and location and location used for fixation will also be gathered for each participant. All data will be deidentified prior to storage in the repository.

Supporting information: Study protocol, Statistical analysis plan

Time frame: Data will be made available at the end of funding, or upon result publication, whichever comes first. As noted above all relevant publications will contain the DOI that points to the relevant data. The data will be stored as long as the OSF repository remains viable; if for some reason alternative storage sites are required within the next 10 years, the PI will pick from others available and transfer the data there.

Access criteria: We will store data on the Open Science Foundation (OSF) repository, available to most people. Computer code will be mirrored there and also stored as github repositories. We will take and store separate "snapshots" corresponding to published protocols and analyses to insure accessibility of older code as projects continue to develop. OSF allows for the creation of a DOI for projects, and a project/DOI pair will be created and associated with each aim of the present proposal. The DOI will be referenced in publications and presentations associated with each project. The behavioral data will be stored in a general purpose format (e.g. csv files), but posted analysis and presentation code will make use of MATLAB. While MATLAB is commercial software, most universities have site licenses available. The analysis code may also run in Octave, an open-source alternative to MATLAB.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Enrollment
100→216
Oct 29, 2026
Show all 1 update
  1. Oct 29, 2026
    Enrollment 100→216
    + 2 other changes: verification date and design details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07216924
Responsible party
Sponsor
First posted
Oct 15, 2025
Start date
Jun 2027 (estimated)
Primary completion
May 2031 (estimated)
Completion
May 2032 (estimated)
Last update
Oct 29, 2026

Study contacts

Stephen A Engel, Ph.D.
Contact
engel@umn.edu
6126255571

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion